Both in Pharmaceuticals
PMGC Holdings vs Karyopharm Therapeutics
Over the past year ELAB returned −99.9% and KPTI returned −98.7%; their daily moves had a correlation of 0.01.
ELAB −99.9% KPTI −98.7%Growth of $1, one year, split-adjusted
| Metric | ELAB | KPTI |
|---|---|---|
| Price | $1.92 | $0.0729 |
| Market cap | $1.6M | $1.7M |
| Today | −1.03% | −17.44% |
| 1 month | −41.3% | −88.8% |
| 6 months | −91.0% | −99.2% |
| Year to date | −99.5% | −99.0% |
| 1 year | −99.9% | −98.8% |
| Revenue growth (YoY) | — | −11.9% |
| Gross margin | 29.5% | 96.8% |
| Net margin | −225.1% | −200.5% |
| P/E (TTM) | — | — |
| Price / sales | 0.6× | 0.0× |
| Net cash | $9.4M | -$184.8M |
| Dividend yield | — | — |
| Volatility (60d) | 677.7% | 413.8% |
| Short % of float | 0.4% | 34.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).